Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Notaro, Sara [VerfasserIn]   i
 Altevogt, Peter [VerfasserIn]   i
Titel:Evaluating L1CAM expression in human endometrial cancer using qRT-PCR
Verf.angabe:Sara Notaro, Daniel Reimer, Michaela Duggan-Peer, Heidi Fiegl, Annamarie Wiedermair, Julia Rössler, Peter Altevogt, Christian Marth, Alain Gustave Zeimet
E-Jahr:2016
Jahr:May 24, 2016
Umfang:12 S.
Fussnoten:Gesehen am 25.06.2019
Titel Quelle:Enthalten in: OncoTarget
Ort Quelle:[Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010
Jahr Quelle:2016
Band/Heft Quelle:7(2016), 26, Seite 40221-40232
ISSN Quelle:1949-2553
Abstract:Background: Management of endometrial carcinoma (EC) still needs improvement of risk assessment. Recently, L1CAM immunohistochemical (IHC) evaluation showed a unique value to predict the outcome of early EC. However IHC results are often conflicting for lack of inter-laboratory standardisation. Methods: Here, as a proof of concept and to increase reproducibility we assayed eighty-two EC and 26 normal endometrium samples for L1CAM expression (L1CAMEXP) via qRT-PCR. The IHC evaluation was performed in 50 cancer samples. Moreover, we aimed to substantiate the in-vitro findings of L1CAM regulation through its promoter methylation (L1CAMMET), miR-34a expression and miR-34a promoter methylation. DNA methylation was assessed with MethyLight PCR technique. Results: High overall concordant results between IHC and RT-PCR evaluations were found. L1CAMEXP was detected in 11% of cancer specimens. These positive cancers exhibited a worse DFS (p=0.032) and OS (p=0.016) in a multivariate COX-regression model. L1CAMEXP predicted distant failure (p=0.007) and L1CAMMET predicted risk-reduction of lymph-node involvement (p=0.005). Inverse correlations between L1CAMEXP and L1CAMMET (p=0.004) and between L1CAMEXP and miR-34a expression (p=0.002) were found. Conclusions: In conclusion qRT-PCR analysis is a reliable approach to evaluate L1CAM status in EC and L1CAMEXP was highly predictive for distant failure and poor outcome, confirming the large IHC-based studies. Interestingly, L1CAMMET was able to assess the risk of pelvic lymph-node involvement. Especially the latter finding has to be confirmed in larger prospective series.
DOI:doi:10.18632/oncotarget.9574
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.18632/oncotarget.9574
 Volltext: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=9574&path[]=29971
 DOI: https://doi.org/10.18632/oncotarget.9574
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1667900072
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68401053   QR-Code
zum Seitenanfang